Steven Cohen's VNDA Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 161,596 shares of Vanda Pharmaceuticals Inc. (VNDA) worth $1.12 M, representing 0.00% of the portfolio. First purchased in 2015-Q2, this medium-term investment has been held for 18 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in VNDA, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2017, adding 2.33 M shares. Largest reduction occurred in Q3 2017, reducing 1.84 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Vanda Pharmaceuticals (VNDA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Vanda Pharmaceuticals (VNDA) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +100,130 | Add 162.90% | 161,596 | $6.91 |
| Q4 2025 | +61,466 | New Buy | 61,466 | $8.82 |
| Q4 2023 | -57,490 | Sold Out | 0 | $0.00 |
| Q3 2023 | +57,490 | New Buy | 57,490 | $4.32 |
| Q1 2021 | -170,000 | Sold Out | 0 | $0.00 |
| Q4 2020 | +170,000 | New Buy | 170,000 | $13.14 |
| Q4 2019 | -223,375 | Sold Out | 0 | $0.00 |
| Q3 2019 | +223,375 | New Buy | 223,375 | $13.28 |
| Q1 2018 | -125,000 | Sold Out | 0 | $0.00 |
| Q4 2017 | +25,000 | Add 25.00% | 125,000 | $15.20 |
| Q3 2017 | -1.84 M | Reduce 94.85% | 100,000 | $17.90 |
| Q2 2017 | -542,100 | Reduce 21.82% | 1.94 M | $16.30 |
| Q1 2017 | +2.33 M | Add 1544.28% | 2.48 M | $14.00 |
| Q4 2016 | -391,600 | Reduce 72.16% | 151,100 | $15.95 |
| Q3 2016 | +542,700 | New Buy | 542,700 | $16.64 |
| Q4 2015 | -1,900 | Sold Out | 0 | $0.00 |
| Q3 2015 | -94,600 | Reduce 98.03% | 1,900 | $11.05 |
| Q2 2015 | +96,500 | New Buy | 96,500 | $12.69 |
Steven Cohen's Vanda Pharmaceuticals Investment FAQs
Steven Cohen first purchased Vanda Pharmaceuticals Inc. (VNDA) in Q2 2015, acquiring 96,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Vanda Pharmaceuticals Inc. (VNDA) for 18 quarters since Q2 2015.
Steven Cohen's largest addition to Vanda Pharmaceuticals Inc. (VNDA) was in Q1 2017, adding 2,484,500 shares worth $34.78 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 161,596 shares of Vanda Pharmaceuticals Inc. (VNDA), valued at approximately $1.12 M.
As of the Q1 2026 filing, Vanda Pharmaceuticals Inc. (VNDA) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Vanda Pharmaceuticals Inc. (VNDA) was 2,484,500 shares, as reported at the end of Q1 2017.